Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance. When MI occurs early in life, genetic inheritance is a major component to risk. Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Do, R, Stitziel, N, Won, H, Jørgensen, AB, Duga, S, Angelica Merlini, P, Kiezun, A, Farrall, M, Goel, A, Zuk, O, Guella, I, Asselta, R, Lange, L, Peloso, G, Auer, P, Girelli, D, Martinelli, N, Farlow, D, DePristo, M, Roberts, R, Stewart, A, Saleheen, D, Danesh, J, Epstein, SE, Sivapalaratnam, S
Format:	Journal article
Język:	English
Wydane:	2014

Podobne zapisy

Inactivating mutations in NPC1L1 and protection from coronary heart disease.
od: Stitziel, N, i wsp.
Wydane: (2014)

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
od: Lander, Eric Steven
Wydane: (2017)

Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction.
od: Aenne S Thormaehlen, i wsp.
Wydane: (2015-02-01)

Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction
od: Thormaehlen, Aenne S., i wsp.
Wydane: (2015)

Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
od: Crosby, J, i wsp.
Wydane: (2014)

Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance?
od: Manal Zabalawi, i wsp.
Wydane: (2007-01-01)

Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia.
od: Stitziel, N, i wsp.
Wydane: (2013)

Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia
od: Stitziel, N, i wsp.
Wydane: (2013)

Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population
od: Ilaria Guella, i wsp.
Wydane: (2010-11-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
od: A. N. Meshkov, i wsp.
Wydane: (2022-11-01)

Differential tissue-specific expression of human apoA-I and apoA-II
od: TL Eggerman, i wsp.
Wydane: (1991-05-01)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
od: R. A. Zorzo, i wsp.
Wydane: (2023-06-01)

Computational and statistical approaches to analyzing variants identified by exome sequencing
od: Stitziel, Nathan O., i wsp.
Wydane: (2012)

Computational and statistical approaches to analyzing variants identified by exome sequencing
od: Stitziel, Nathan O., i wsp.
Wydane: (2012)

SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
od: Veneracion G. Cabana, i wsp.
Wydane: (1999-06-01)

Phenotypic characterization of genetically lowered human lipoprotein(a) levels
od: Emdin, C, i wsp.
Wydane: (2016)

ApoA-I and Cancer
od: Maryam eZamanian-Daryoush, i wsp.
Wydane: (2015-11-01)

Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-/- mice
od: D.M. Grosso, i wsp.
Wydane: (2008-12-01)

Clinical characteristics of carriers of pathogenic LDLR and АРОВ mutations
od: Z. F. Kim, i wsp.
Wydane: (2024-02-01)

Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
od: Yanhua Wu, i wsp.
Wydane: (2016-01-01)

GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex
od: Mark A. Deeg, i wsp.
Wydane: (2001-03-01)

LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL
od: Kaihan Wang, i wsp.
Wydane: (2024-03-01)

Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
od: Elvezia Maria Paraboschi, i wsp.
Wydane: (2018-12-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
od: Maria C. de Beer, i wsp.
Wydane: (2005-10-01)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
od: Kuang-Yuh eChyu, i wsp.
Wydane: (2015-09-01)

ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method
od: K Ikewaki, i wsp.
Wydane: (1996-02-01)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
od: Ma S, i wsp.
Wydane: (2019-08-01)

A dual-reporter LDLR system integrating fluorescence and luminescence for understanding LDLR regulation and facilitating drug discovery
od: Peng Jiao, i wsp.
Wydane: (2025-03-01)

Targeting the Apoa1 locus for liver-directed gene therapy
od: Marco De Giorgi, i wsp.
Wydane: (2021-06-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
od: William M. Brown J.D., Ph.D., i wsp.
Wydane: (2008-01-01)

Sexual dimorphism in atherosclerotic plaques of aged Ldlr −/− mice
od: Virginia Smit, i wsp.
Wydane: (2024-05-01)

First Replication of the Involvement of OTUD6B in Intellectual Disability Syndrome With Seizures and Dysmorphic Features
od: Letizia Straniero, i wsp.
Wydane: (2018-10-01)

Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia
od: Jian Wang, i wsp.
Wydane: (2005-02-01)

ApoA-I mimetics: tomatoes to the rescue1
od: Godfrey S. Getz, i wsp.
Wydane: (2013-04-01)

The enigma of soluble LDLR: could inflammation be the key?
od: Majambu Mbikay, i wsp.
Wydane: (2020-02-01)

ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis[S]
od: Yaoyong Wang (王耀勇), i wsp.
Wydane: (2011-08-01)

Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
od: Kelli A Lytle, i wsp.
Wydane: (2016-01-01)

Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells
od: N Dashti, i wsp.
Wydane: (1996-04-01)

Genes of APOA5 and APOH apoliproteins as regulators of lipoprotein metabolism
od: N. S. Shirokova, i wsp.
Wydane: (2020-09-01)

Polimorfismos de los genes LEP, LDLR, APOA4 y sus relaciones con el sobrepeso, la obesidad y el riesgo de enfermedades crónicas en adultos del estado Sucre, Venezuela
od: Greta Rodríguez-Arroyo, i wsp.
Wydane: (2016-03-01)